Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia

Urology

Volumn 83, Issue 6, 2014, Pages 1444.e7-1444.e13

  Vanella, Luca ^a   Russo, Giorgio Ivan ^a   Cimino, Sebastiano ^a   Fragalà, Eugenia ^a   Favilla, Vincenzo ^a   Li Volti, Giovanni ^a   Barbagallo, Ignazio ^a   Sorrenti, Valeria ^a   Morgia, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHOLESTEROL, HDL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEME OXYGENASE (DECYCLIZING); HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION OF PROSTATE; TRIGLYCERIDES;

EID: 84901398410     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.03.007     Document Type: Article

References (30)

1. C. De Nunzio, W. Aronson, and S.J. Freedland et al. The correlation between metabolic syndrome and prostatic diseases Eur Urol 61 2012 560 570
2. Y.W. Park, S.B. Kim, and H. Kwon et al. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome Urology 82 2013 674 679
3. V. Kupelian, K.T. McVary, and S.A. Kaplan et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey J Urol 189 Suppl 1 2013 S107 S114 discussion S15-6
4. Y.J. Yang, S.H. Lee, S.J. Hong, and B.C. Chung Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia Clin Biochem 32 1999 405 409
5. M. El Assar, J. Angulo, and L. Rodriguez-Manas Oxidative stress and vascular inflammation in aging Free Radic Biol Med 65 2013 380 401
6. S. Turkseven, A. Kruger, and C.J. Mingone et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes Am J Physiol Heart Circ Physiol 289 2005 H701 H707
7. A. Nicolai, M. Li, and D.H. Kim et al. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats Hypertension 53 2009 508 515
8. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol Rev 60 2008 79 127
9. N.G. Abraham, P.L. Tsenovoy, J. McClung, and G.S. Drummond Heme oxygenase: a target gene for anti-diabetic and obesity Curr Pharm Des 14 2008 412 421
10. J.E. Clark, R. Foresti, C.J. Green, and R. Motterlini Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress Biochem J 348 Pt 3 2000 615 619
11. L. Vanella, G. Li Volti, and S. Guccione et al. Heme oxygenase-2/ adiponectin protein-protein interaction in metabolic syndrome Biochem Biophys Res Commun 432 2013 606 611
12. L. Vanella, D.H. Kim, and K. Sodhi et al. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes Prostaglandins Other Lipid Mediat 96 2011 54 62
13. D. Tibullo, I. Barbagallo, and C. Giallongo et al. Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells Curr Pharm Des 19 2013 2765 2770
14. L. Salerno, V. Pittala, and G. Romeo et al. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties Bioorg Med Chem 21 2013 5145 5153
15. L. Vanella, C. Di Giacomo, and R. Acquaviva et al. Effects of ellagic acid on angiogenic factors in prostate cancer cells Cancers 5 2013 726 738
16. M.D. Maines, and P.A. Abrahamsson Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution Urology 47 1996 727 733
17. S.J. Peterson, D.H. Kim, and M. Li et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice J Lipid Res 50 2009 1293 1304
18. V. Favilla, S. Cimino, and C. Salamone et al. Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12months follow-up J Endocrinol Invest 36 2013 1094 1098
19. S.W. Ryter, J. Alam, and A.M. Choi Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications Physiol Rev 86 2006 583 650
20. S. Rohrmann, E. Smit, E. Giovannucci, and E.A. Platz Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 2005 310 316
21. S.E. Dahle, A.P. Chokkalingam, and Y.T. Gao et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 2002 599 604
22. M.R. Freeman, and K.R. Solomon Cholesterol and benign prostate disease Differentiation 82 2011 244 252
23. K. Sodhi, K. Inoue, and K.H. Gotlinger et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice J Pharmacol Exp Ther 331 2009 906 916
24. M.P. Hamilton, M.O. Gore, and C.R. Ayers et al. Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution Diab Vasc Dis Res 8 2011 190 194
25. G.A. Rutter, G. Da Silva Xavier, and I. Leclerc Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis Biochem J 375 2003 1 16
26. G. Zadra, C. Priolo, A. Patnaik, and M. Loda New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK Clin Cancer Res 16 2010 3322 3328
27. K.A. Brown, N.U. Samarajeewa, and E.R. Simpson Endocrine-related cancers and the role of AMPK Mol Cell Endocrinol 366 2013 170 179
28. M. Gacci, L. Vignozzi, and A. Sebastianelli et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation Prostate Cancer Prostatic Dis 16 2013 101 106
29. Y. Zhao, L. Zhang, and Y. Qiao et al. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy PloS One 8 2013 e75927
30. A. Tuncel, B. Uzun, and T. Eruyar et al. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention? Eur Urol 48 2005 277 283 discussion 83-4